Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3376222 | Journal of Infection | 2007 | 4 Pages |
Abstract
SummaryWe report a case of severe AVP three weeks following the administration of infliximab for the treatment of Crohn's disease (CD). Since the introduction of tumor necrosis factor-alpha (TNF-α) antagonists, various microbiologic agents have been reported to cause pneumonia following their administration. To our knowledge, AVP following therapy with TNF-α antagonists has not been reported in English literature. We present a brief review of the mechanism of action of TNF-α antagonists and their ability to predispose to various infections including viral pneumonia by interfering with the immune response.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Nasir M. Ahmad, Khalid M. Ahmad, Faheem Younus,